Primary |
Drug Use For Unknown Indication |
30.7% |
Product Used For Unknown Indication |
23.8% |
Bronchiolitis |
7.9% |
Antibiotic Prophylaxis |
4.0% |
Convulsion |
3.0% |
Cough |
3.0% |
Diffuse Panbronchiolitis |
3.0% |
Pneumonia |
3.0% |
Postoperative Wound Infection |
3.0% |
Cardiac Failure Chronic |
2.0% |
Epilepsy |
2.0% |
Gastrooesophageal Reflux Disease |
2.0% |
Infection |
2.0% |
Nasopharyngitis |
2.0% |
Pain |
2.0% |
Primary Ciliary Dyskinesia |
2.0% |
Supraventricular Tachycardia |
2.0% |
Bronchitis |
1.0% |
Chronic Obstructive Pulmonary Disease |
1.0% |
Corneal Cyst |
1.0% |
|
Tachycardia |
13.0% |
Vomiting |
8.7% |
Acidosis |
4.3% |
Angioedema |
4.3% |
Arrhythmia |
4.3% |
Blood Potassium Decreased |
4.3% |
Cardiac Disorder |
4.3% |
Condition Aggravated |
4.3% |
Deafness |
4.3% |
Eczema |
4.3% |
Electrolyte Imbalance |
4.3% |
Fall |
4.3% |
Flatulence |
4.3% |
Heart Rate Decreased |
4.3% |
Hepatic Function Abnormal |
4.3% |
Hepatitis Fulminant |
4.3% |
Hypersensitivity |
4.3% |
Malaise |
4.3% |
Nausea |
4.3% |
Neutropenia |
4.3% |
|
Secondary |
Product Used For Unknown Indication |
43.4% |
Drug Use For Unknown Indication |
8.8% |
Pneumonia |
6.2% |
Prophylaxis |
5.3% |
Bronchitis |
4.4% |
Colorectal Cancer |
4.4% |
Rheumatoid Arthritis |
4.4% |
Skin Test |
3.5% |
Tooth Infection |
3.5% |
Antibiotic Prophylaxis |
2.7% |
Bronchial Hyperreactivity |
1.8% |
Gastrointestinal Infection |
1.8% |
Lower Respiratory Tract Infection |
1.8% |
Lung Abscess |
1.8% |
Pertussis |
1.8% |
Anaemia |
0.9% |
Bronchitis Chronic |
0.9% |
Constipation |
0.9% |
Delirium |
0.9% |
Diffuse Panbronchiolitis |
0.9% |
|
Pancreatitis |
10.0% |
Respiratory Failure |
10.0% |
Skin Test Positive |
10.0% |
Cardio-respiratory Arrest |
5.0% |
Drug Hypersensitivity |
5.0% |
Drug Reaction With Eosinophilia And Systemic Symptoms |
5.0% |
Eczema |
5.0% |
Interstitial Lung Disease |
5.0% |
Oral Discomfort |
5.0% |
Pneumonia |
5.0% |
Pulmonary Sarcoidosis |
5.0% |
Renal Failure Acute |
5.0% |
Sinusitis |
5.0% |
Swelling Face |
5.0% |
Toxic Skin Eruption |
5.0% |
Urine Output Decreased |
5.0% |
Vomiting |
5.0% |
|
Concomitant |
Rheumatoid Arthritis |
17.7% |
Drug Use For Unknown Indication |
8.1% |
Gastritis |
7.0% |
Pneumonia |
6.7% |
Diabetes Mellitus |
5.9% |
Type 2 Diabetes Mellitus |
5.4% |
Chronic Obstructive Pulmonary Disease |
5.1% |
Hypertension |
4.6% |
Cardiac Failure |
4.0% |
Cough |
4.0% |
Infection |
4.0% |
Angina Pectoris |
3.8% |
Asthma |
3.5% |
Osteoporosis |
3.2% |
Bronchitis Chronic |
3.0% |
Cellulitis |
3.0% |
Pain |
3.0% |
Cerebral Palsy |
2.7% |
Constipation |
2.7% |
Diabetic Neuropathy |
2.7% |
|
Death |
9.8% |
Upper Gastrointestinal Haemorrhage |
8.2% |
Intestinal Ischaemia |
6.6% |
Pneumonia |
6.6% |
Hypoglycaemia |
4.9% |
Interstitial Lung Disease |
4.9% |
Pancytopenia |
4.9% |
Pneumonia Bacterial |
4.9% |
Pyrexia |
4.9% |
Renal Failure |
4.9% |
Respiratory Failure |
4.9% |
Tremor |
4.9% |
Tumour Haemorrhage |
4.9% |
White Blood Cell Count Decreased |
4.9% |
Aortic Dissection |
3.3% |
Dyskinesia |
3.3% |
Epilepsy |
3.3% |
Gastric Ulcer |
3.3% |
Pleural Effusion |
3.3% |
Vomiting |
3.3% |
|
Interacting |
Pneumonia |
16.7% |
Acne |
12.5% |
Bronchiectasis |
12.5% |
Drug Eruption |
8.3% |
Restlessness |
8.3% |
Bronchitis Chronic |
4.2% |
Chronic Obstructive Pulmonary Disease |
4.2% |
Delirium |
4.2% |
Dementia Alzheimer's Type |
4.2% |
Hyperparathyroidism Secondary |
4.2% |
Insomnia |
4.2% |
Myasthenia Gravis |
4.2% |
Parenteral Nutrition |
4.2% |
Pyrexia |
4.2% |
Rheumatoid Arthritis |
4.2% |
|
Drug Interaction |
33.3% |
Renal Impairment |
33.3% |
Rhabdomyolysis |
33.3% |
|